SCHEMBL30926579

SCHEMBL30926579

O=C(Nc1cccc([N+](=O)[O-])c1)c1cc(S(=O)(=O)Nc2ccc(Br)cc2)ccc1Cl

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 7/20 0.69
KMT2A Q03164 7/20 0.69
MAPK1 P28482 2/20 0.66
SMN1; SMN2 Q16637 2/20 0.66
HTT P42858 1/20 0.66
TP53 P04637 2/20 0.59
CASP3 P42574 1/20 0.55
SENP8 Q96LD8 1/20 0.55
SENP7 Q9BQF6 1/20 0.55
SENP6 Q9GZR1 1/20 0.55
LMNA P02545 1/20 0.55
CYP1A2 P05177 1/20 0.55
CYP3A4 P08684 1/20 0.55
CYP2D6 P10635 1/20 0.55
MAPT P10636 1/20 0.55
CYP2C9 P11712 1/20 0.55
PKM P14618 1/20 0.55
TSHR P16473 1/20 0.55
NFKB1 P19838 1/20 0.55
CYP2C19 P33261 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27180141 1.00 MEN1 (0.69) MEN1KMT2AMAPK1SMN1; SMN2HTT
SCHEMBL27179770 0.92 MEN1 (0.71) MEN1KMT2AMAPK1SMN1; SMN2HTT
SCHEMBL27180767 0.92 MEN1 (0.77) MEN1KMT2AMAPK1SMN1; SMN2HTT
SCHEMBL27181571 0.90 MEN1 (0.69) MEN1KMT2AMAPK1SMN1; SMN2HTT
SCHEMBL27180103 0.87 MEN1 (0.68) MEN1KMT2AMAPK1SMN1; SMN2HTT
SCHEMBL27179440 0.86 MEN1 (0.69) MEN1KMT2AMAPK1SMN1; SMN2HTT
SCHEMBL29562764 0.85 CASP3 (0.76) MEN1KMT2ASMN1; SMN2HTTCASP3
SCHEMBL14125535 0.85 CASP3 (0.76) MEN1KMT2ASMN1; SMN2HTTCASP3
SCHEMBL7121693 0.83 KMT2A (0.68) MEN1KMT2AMAPK1SMN1; SMN2HTT
SCHEMBL29385655 0.82 MEN1 (0.58) MEN1KMT2AMAPK1SMN1; SMN2HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240099300-A1 SULFONAMIDE APYRASE INHIBITORS TEXAS CROP SCIENCE, INC. 2024-03-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240099300-A1 SULFONAMIDE APYRASE INHIBITORS APEH, ARSA, DNPEP MEN1 4795/4885KMT2A 2544/4885MAPK1 2851/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.